Author(s): Aya T. Soudi, Ola G. Hussein, Eman S. Elzanfaly, Hala E. Zaazaa, Mohamed Abdelkawy

Email(s): aya.soudi@pharma.cu.edu.eg

DOI: 10.5958/0974-360X.2020.00904.X   

Address: Aya T. Soudi1*, Ola G. Hussein2, Eman S. Elzanfaly1, Hala E. Zaazaa1, Mohamed Abdelkawy2
1Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
2Pharmaceutical Chemistry Department, Faculty of Pharmaceutical Science and Pharmaceutical Industries, Future University in Egypt, Cairo, Egypt.
*Corresponding Author

Published In:   Volume - 13,      Issue - 11,     Year - 2020


ABSTRACT:
Stability indicating methods are essential to determine the stability of newly developed dosage forms. In this work a simple stability-indicating thin-layer chromatographic (TLC) method was developed and validated to determine Alcaftadine in presence of its main degradation products and preservative benzalkonium chloride in bulk powder and in pharmaceutical formulations. Separation was developed on TLC aluminum plates precoated with silica gel 60F-254 as a stationary phase using chloroform: methanol: ammonia (5:5:0.1, by volume) as a developing system. Densitometric scanning was carried out in the absorbance mode at 282nm. Alcaftadine was subjected to oxidation, acid and alkaline hydrolysis. It was observed that the drug is susceptible to oxidation only. Method validation was carried out according to ICH guidelines and the proposed method was successfully applied to analyze alcaftadine in pharmaceutical dosage form with no interference from dosage form additives or preservatives. Linearity range was found to be 0.50 - 12.00µg/band with a good linear relationship r of 0.9998. Results obtained by the proposed TLC-densitometric method were statistically compared with those obtained by a reported spectrophotometric method and no differences were found.


Cite this article:
Aya T. Soudi, Ola G. Hussein, Eman S. Elzanfaly, Hala E. Zaazaa, Mohamed Abdelkawy. Stability Indicating TLC–Densitometric Method for Determination of Alcaftadine in Presence of its Degradation Products and Dosage form Preservatives. Research J. Pharm. and Tech. 2020; 13(11):5171-5176. doi: 10.5958/0974-360X.2020.00904.X


REFERENCES:
1.    Poole CF, and Poole SK. Progress in densitometry for quantitation in planar chromatography. Journal of Chromatography B: Biomedical Sciences and Applications.1989; 492: p. 539-584.
2.    Agrawal H, Kaul N, Paradkar AR, and Mahadik KR. Stability indicating HPTLC determination of clopidogrel bisulphate as bulk drug and in pharmaceutical dosage form. Talanta. 2003; 61(5): pp.581-589.
3.    Kothapalli LP, Vighne KS, Nanda RK, and Thomas AB. Development and Validation of a Stability Indicating HPTLC Method for Estimation of Artemether in Bulk and Formulated dosage form. Asian Journal of Research in Chemistry. 2015; 8(10): pp.635-642.
4.    Kumar M, Rao JR, Yadav SS, and Sathiyanarayanan L. Development and Validation of a Stability-Indicating HPTLC Method for Analysis of Bumetanide in the Bulk Drug and Tablet Dosage Form. Research Journal of Pharmacy and Technology. 2010; 3(1): pp.239-243.
5.    Deshpande K, Ranaware P, Madgulkar AR, and Damle MC. Development and validation of stability indicating HPTLC method for determination of repaglinide. Research Journal of Pharmacy and Technology. 2013; 6(2): pp.158-161.
6.    Rank M, Kapupara P, and Shah K. Development and validation of stability indicating HPTLC method for pioglitazone hydrochloride and metformin hydrochloride. Research Journal of Pharmacy and Technology. 2016; 9(10): pp.1555-1561.
7.    Arous B, Al-Mardini MA, Ghazal H, and Al-Lahham F. Stability-Indicating Method for the Determination of Rivaroxaban and its Degradation Products using LC-MS and TLC. Research Journal of Pharmacy and Technology. 2018; 11(1): pp.212-220.
8.    Renger B. Proceeding of the Sixth International Symposium on Instrumental Planar Chromatography, Institute for Chromatograghy, Bad Duerkheim. 1991; 291.
9.    Sutar SV, and Yeligar VC. Degradation Kinetic Study of Melatonin in Alkaline and Acidic Medium by Validated Stability Indicating HPTLC Method. Research Journal of Pharmacy and Technology. 2020; 13(2): pp.523-528.
10.    Bakshi M, and Singh S. Development of validated stability-indicating assay methods—critical review. Journal of pharmaceutical and biomedical.2002.
11.    Kallepalli P, and Annapurna MM. Separation, Identification and Quantification of process related Impurities and Stress Degradants of Olaparib by LC-ESI-Q-TOF-MS. Research Journal of Pharmacy and Technology. 2018; 11(8): pp.3718-3726.
12.    Sutar SV, Yeligar VC, and Patil SS. Stability Indicating Forced Degradation Studies. Research Journal of Pharmacy and Technology. 2019; 12(1): pp.429-433.
13.    Kushwaha P. Significance of Stability Studies on Degradation Product. Research Journal of Pharmacy and Technology. 2009; 2(4): pp.621-627.
14.    Mathew N, Jacob JT, and Nadig S. Stability Indicating Degradation Behaviour of Artesunate Under stress conditions. Research Journal of Pharmacy and Technology.2018; 11(12): pp.5587-5592.
15.    Singh, Saranjit, and Bakshi M. "Guidance on the conduct of stress tests to determine inherent stability of drugs." Pharmaceutical Technology Asia. 2000; 24-24.
16.    Connors KA, Amidon GL, and Stella VJ. Chemical stability of pharmaceuticals: a handbook for pharmacists. John Wiley and Sons analysis.1986; 28(6): pp.1011-1040.
17.    Bohets H, McGowan C, Mannens G, Schroeder N, Edwards-Swanson K, and Shapiro A. Clinical pharmacology of alcaftadine, a novel antihistamine for the prevention of allergic conjunctivitis. Journal of ocular pharmacology and therapeutics. 2011; 27(2): pp.187-195.
18.    Greiner JV, Edwards-Swanson K, and Ingerman A. Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%. Clinical ophthalmology (Auckland, NZ). 2011; 5: p.87.
19.    Namdar R, and Valdez C. Alcaftadine: a topical antihistamine for use in allergic conjunctivitis. Drugs of today (Barcelona, Spain: 1998). 2011; 47(12): pp.883-890.
20.    Chemistry Review http://www.accessdata.fda.gov/ drugsatfda_docs/nda/2010/022134s000ChemR.pdf. Accessed 16 Mar 2015).
21.    Domagk G. Eine neue klasse von desinfektionsmitteln. DMW-Deutsche Medizinische Wochenschrift. 1935; 61(21): pp.829-832.
22.    Baudouin C, Labbé A, Liang H, Pauly A, and Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Progress in retinal and eye research. 2010; 29(4): pp.312-334.
23.    Mishra PR, Satone D, and Meshram DB. Development and Validation of HPLC Method for the Determination of Alcaftadine in Bulk Drug and its Ophthalmic Solution. J Chromatogr Sep Tech. 2016; 7(312): p.2.
24.    Mishra PR, Inamdar P, Jamdar P, Patel N, Rohit M, Satone D, and Meshram DB. Development and validation of UV-spectrophotometry and the first order derivative using the area under curve method for the estimation of alcaftadine in bulk and its ophthalmic dosage form. FS J Pharm Res. 2015; 4(1): pp.9-13.
25.    Chavan BB, Kalariya PD, Srinivas R. and Talluri MK. Alcaftadine: Selective Separation and Characterization of Degradation Products by LC–QTOF-MS/MS. Chromatographia. 2018; 81(4): pp.631-638.
26.    Szepesi G, Gazdag M, in: J. Sherma, B. Fried (Eds.), Handbook of Thin Layer Chromatography, Marcel Dekker Inc., New York. 1996; pp. 685–703.
27.    ICH.; Validation of Analytical Procedures: Methodology, ICH- Q2(R1). In: International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use. 2005.

Recomonded Articles:

Author(s): Ravindranath S. Misal, Vishawas R. Potphode, Vijay R. Mahajan

DOI: 10.5958/0974-360X.2017.00218.9         Access: Open Access Read More

Author(s): Niharika, Navneet Verma

DOI: 10.5958/0974-360X.2016.00182.7         Access: Open Access Read More

Author(s): A. S. K. Sankar, B. Datchayani, N. Balakumaran, Mohammed Rilwan, R. Subaranjani

DOI: 10.5958/0974-360X.2017.00047.6         Access: Open Access Read More

Author(s): U.S Mahadeva Rao, Khamsah Suryati Mohd, Abdurrazaq Muhammad, Bashir Ado Ahmad, Mohaslinda Mohamad, Rosmawati Mat Ali

DOI: Not Available         Access: Open Access Read More

Author(s): Rekha Rajendran, R Hemachander, T Ezhilarasan, C Keerthana, DL Saroja, KV Saichand, Mohamed Gasim Abdullah

DOI: Not Available         Access: Open Access Read More

Author(s): Archana Kushwaha, Jayanti Jaiswal, Priya Singh, Neha Rathore, Jai Prakash Dhruw, Ishu Sahu, Chhaya Singh, Krinsha Kumar Sahu, Mukta Agrawal, D. K. Tripathi, Ajazuddin, Amit Alexander

DOI: 10.5958/0974-360X.2017.00270.0         Access: Open Access Read More

Author(s): Narendra Chotai, Vishnu Patel, Harsha Patel, Uren Patel, Rajendra Kotadiya

DOI:         Access: Open Access Read More

Author(s): Mukta D. Naykode, Durgacharan A. Bhagwat, Swapnil D. Jadhav, Harinath N. More

DOI: 10.5958/0974-360X.2017.00133.0         Access: Open Access Read More

Author(s): Mayanka Singh, Manoj Charde, Rajesh Shukla, Rita M. Charde

DOI: Not Available         Access: Open Access Read More

Author(s): Homendra Kumar Sahu, Kamdev Sen, Raju Patel, Hulash Sahu, Deepika Sahu, Gulshan Sahu, Chandrashekhar Jain, Narayan Prasad Chandra, Mukta Agrawal, D. K. Tripathi, Ajazuddin, Amit Alexander

DOI: 10.5958/0974-360X.2017.00173.1         Access: Open Access Read More

Author(s): Hemlata M. Nimje, Rajesh J. Oswal, Sandip S. Kshirsagar, Manoj Chavan

DOI: Not Available         Access: Open Access Read More

Author(s): Vikram Kumar Sahu, Amit Mishra, Nitin Sharma, Pratap Kumar Sahu, Shubhini A. Saraf

DOI: 10.5958/0974-360X.2017.00048.8         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags